What is Health Sciences Gr?
, through its subsidiaries, provides various products used in nutritional supplements and functional foods and beverages in the United States.
HESG · Verdict
Solid reward · elevated risk
HESG stands out on valuation and growth, but watch the volatility signal.
Based on 88% data coverage
HESG · Verdict
Above average
Rev +81.3% CAGR · earnings -78.8%
Weak vs peers
-15% net margin · 0% ROE
12% free-cash-flow margin
Model-based scoring. For information only — not financial advice.
, through its subsidiaries, provides various products used in nutritional supplements and functional foods and beverages in the United States. It primarily offers Shugr, a zero-calorie sugar substitute that tastes and bakes like cane sugar; and Sequesterol Advance Cardio Formula, a proprietary blend of clinically studied ingredients for the maintenance of cardiovascular health and a free-flowing circulatory system. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 28.15K.
The scoring profile indicates moderate reward potential, with valuation and growth as the leading contributors. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.